Poster session at IFSCC 2024 with Exsymol
octobre 7, 2024
Our Collaboration with Exsymol Monaco at the 34th Congress IFSCC Brazil 2024 We are excited to announce that our scientific research work performed in collaboration
We are pleased to announce our participation in the COSMETIC 360 exhibition, which will be held in Paris on October 16th and 17th 2024.
COSMETIC 360 is the global showcase of innovation for the cosmetic industry. This key event will be an opportunity to present our latest innovations and applications for dermo-cosmetic research, including our new ex vivo tissue models to support claims on facial care, such as dark circles, under eye bags and under eye sagging.
These models are designed to provide reliable data on active ingredients and products effectiveness, allowing brands to substantiate their claims in an innovative way. Through our approaches, we offer solutions to support claims in the field of dark circles, eye bags, puffy eyes and under eye sagging, giving new life to cosmetic active ingredients and products.
Visit us at booth DB19 in the Research Area to discover these new methods and discuss current industry trends. ExAdEx-Innov is committed to supporting sustainability and innovation in the cosmetics industry, and we would love to meet you!
Stay tuned for more information as we approach this unmissable event!
COSMETIC-360 2024
WHERE: Paris, Carrousel du Louvre
WHEN: October 16-17, 2024
BOOTH: DB19 (Research Area – MED’INNOV Booth)
For more information about the exhibition, check the congress website here
Our Collaboration with Exsymol Monaco at the 34th Congress IFSCC Brazil 2024 We are excited to announce that our scientific research work performed in collaboration
Organoid models developed by ExAdEx-Innov and collaborators presented at the 3R LÄND CONFERENCE 2024 in Tübingen (Germany) Latest work from ExAdEx-Innov team on clinically relevant
Scientific work performed by ExAdEx-Innov researchers and collaborators will be presented during European Congress on Obesity ECO 2024 Latest work on adipose tissue and obesity
Copyright © 2022 ExAdEx-Innov All rights reserved
KOL on adipose tissue biology.
Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice).
Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program).
Co-inventor of 5 patents
Expert in clinical applications of adipose tissue.
Plastic Reconstructive and Aesthetic Surgeon in Nice.
Member of the Medical Council of Alpes Maritimes region.
Expert for the French National Regulatory Agency ANSM for medical devices.
Certified by French Health Autority HAS (2020-2024).
PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.
Expert in cell therapy and immunology.
Senior Lecturer (Maitre de conférences).
Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).
Director of « Micoralis » research team at Université Côte d’Azur (Nice).
Founder and CEO of the biotech company Biointerférence (2003-2006).
Co-inventor of 5 patents.
Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.
With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov.
In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille).
He is co-inventor of the 2 company’s patent families.
Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue.
Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.
With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years.
He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.
Main areas of expertise: Biotech Startup Business Development; Project management